Effect of haemodialysis after contrast medium administration in patients with renal insufficiency

Nephrology Dialysis Transplantation

Volumn 13, Issue 2, 1998, Pages 358-362

  Lehnert, Thomas ^a   Keller, Erich ^a   Gondolf, Klaus ^a   Schäffner, Tanja ^a   Pavenstädt, Hermann ^a   Schollmeyer, Peter ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Haemodialysis; Iopentol; Radiocontrast nephropathy

Indexed keywords

CONTRAST MEDIUM; CREATININE; IOPENTOL;

ADULT; ANGIOGRAPHY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG HALF LIFE; EXTRACORPOREAL CIRCULATION; FEMALE; HEMODIALYSIS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY FUNCTION; MALE; PLASMA CLEARANCE; PRIORITY JOURNAL; RADIOCONTRAST NEPHROPATHY; RANDOMIZED CONTROLLED TRIAL;

EID: 0031976079     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.ndt.a027830     Document Type: Article

References (20)

1. Parfrey PS, Griffiths SM, Barrett BJ et al. Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. A prospective controlled study. N Engl J Med 1989; 320: 143-149
2. Heyman SN, Brezis M, Epstein FH, Spokes K, Silva P, Rosen S. Early renal medullary hypoxic injury from radiocontrast and indomethacin. Kidney Int 1991; 40: 632-642
3. Solomon R, Werner C, Mann D, D'ellia J, Silva P. Effects of saline, mannitol, and furosemide on acute decreases in renal function induced by radiocontrast agents. N Engl J Med 1995; 331: 1416-1420
4. Neumayer HH, Junge W, Kufner A, Wenning A. Prevention of radiocontrast-media-induced nephrotoxicity by the calcium channel blocker nitrendipine: a prospective randomized clinical trial. Nephrol Dial Transplant 1989; 4: 1030-1036
5. Heyman SN, Clark BA, Kaiser N et al. Radiocontrast agents induce endothelin release in vivo and in vitro. J Am Soc Nephrol 1992; 3: 58-65
6. Cantley GC, Spokes K, Clark B, Mcmahon EG, Carter J, Epstein FH. Role of endothelin and prostaglandins in radiocontrast-induced renal artery constriction. Kidney Int 1993; 44: 1217-1223
7. Erley CM, Duda SH, Schlepckow S et al. Adenosine antagonist theophylline prevents the reduction of glomerular filtration rate after contrast media application. Kidney Int 1994; 45: 1425-1431
8. Gandhi MR, Brown P, Romanowski CA et al. The use of theophylline, an adenosine antagonist in the prevention of contrast media induced nephrotoxicity (letter) (corrected and republished letter originally printed in Br J Radiol 1992; 65: 459). Br J 1992; 65: 838
9. Weisberg LS, Kurnik PB, Kurnik BR. Risk of radiocontrast nephropathy in patients with and without diabetes mellitus. Kidney Int 1994; 45: 259-265
10. Hall KA, Wong RW, Hunter GC et al. Contrast-induced nephrotoxicity: the effects of vasodilator therapy. J Surg Res 1992; 53: 317-320
11. Moon SS, Bäck SE, Kurkus J, Nilsson-Ehle P. Hemodialysis for elimination of the nonionic contrast medium lohexol after angiography in patients with impaired renal function. Nephron 1995; 70: 430-437
12. Kierdorf H, Kindler J, Winterscheid R, Hollmann HJ, Vorwerk D, Speck U. Elimination of the nonionic contrast medium iopromide in end-stage renal failure by hemodialysis. In: Taenzer V, Wende S, ed. Recent Developments in Nonionic Contrast Media. Thieme, Stuttgart, 1989; 119-123
13. Baars HG, Schabel J, Weiss M. Kontrastmittelelimination durch Hämodialyse. Z Urol Nephrol 1984; 77 :473-481
14. Erley CM, Duda SH. Nephropathy due to contrast media. Its pathogenesis and prevention. (Review). Dtsch Med Wochenschr 1995; 120: 806-810
15. Skinnemoen K. Physicochemical properties and degree of protein binding of iopentol. Acta Radiol 1987; [Suppl 370]: 33-36
16. Hou SH, Bushinsky DA, Wish JB, Cohen JJ, Harrington JT. Hospital-acquired renal insufficiency: a prospective study. Am J Med 1983; 74: 243-248
17. Shusterman N, Strom BL, Murray TG, Morrison G, West SL, Maislin G. Risk factors and outcome of hospital acquired acute renal failure. Am J Med 1987; 83: 65-71
18. Svaland MG, Kolmannskog F, Lillevold PE, Nordal K, Ressem L, Berg KJ. Pharmacokinetics of iopentol in patients with chronic renal failure. Acta Radiol 1992; 33: 482-484
19. Lautin EM, Freeman NJ, Schoenfeld AH et al. Radiocontrast-associated renal dysfunction: incidence and risk factors. AJR 1991; 157: 49-58
20. Russo D, Minutolo R, Cianciaruso B, Memoli B, Conte G, DE Nicola L. Early effects of contrast media on renal hemodynamics and tubular function in chronic renal failure. J Am Soc Nephrol 1995; 6: 1451-1458